Clinical Trials for Rectal Cancer
5 Open Trials
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCMD1188 06/08/2012 | An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers |
| Epidemiology, Observation, Outcomes | ACOSOGGIZ6051 09/25/2009 | A Phase III Prospective Trial Comparing Laparoscopic-Assisted Resection vs. Open Resection for Rectal Cancer |
| Epidemiology, Observation, Outcomes | VICCGI0721 01/09/2007 | Vanderbilt Hereditary Colorectal Cancer Registry |
| Screen, Detect, Diagnose | VICCMD1286 12/17/2012 | Screening Protocol to Detect BRAF V600 Mutation Positive Patients for Enrollment into Clinical Research Studies of Vemurafenib |
| Screen, Detect, Diagnose | VICCGI1156 02/03/2012 | Research use of human biospecimens from colorectal cancer patients and clinical testing for the assignment of therapy |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
